{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:01:37Z","timestamp":1772136097202,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Corneal neovascularization (CNV) causes higher-order aberrations, corneal edema, ocular inflammation, and corneal transplant rejection, thereby decreasing visual acuity. In this study, we investigated the effects of topical administration of the kappa opioid receptor agonist nalfurafine (TRK-820) on CNV. To induce CNV, intrastromal corneal sutures were placed on the corneal stroma of BALB\/c mice for 2\u00a0weeks. Nalfurafine (0.1\u00a0\u00b5g\/2\u00a0\u03bcL\/eye) was topically administered to the cornea once or twice daily after CNV induction. The CNV score, immune cell infiltration, and mRNA levels of angiogenic and pro-inflammatory factors in neovascularized corneas were evaluated using slit-lamp microscopy, immunohistochemistry, flow cytometry, and polymerase chain reaction. The mRNA expression of the kappa opioid receptor gene\n                    <jats:italic>Oprk1<\/jats:italic>\n                    was significantly upregulated following CNV induction. Topical administration of nalfurafine twice daily significantly suppressed CNV and lymphangiogenesis, as well as reduced the mRNA levels of angiogenic and pro-inflammatory factors in the neovascularized corneas. Moreover, nalfurafine administration twice daily reduced the numbers of infiltrating leukocytes, neutrophils, macrophages, and interferon-\u03b3-producing CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells in the neovascularized corneas. In this study, we demonstrated that topical administration of nalfurafine suppressed local CNV in a mouse model along with the activation of KOR, suggesting that nalfurafine may prevent and control CNV in humans.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-88118-6","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T06:44:41Z","timestamp":1618987481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation"],"prefix":"10.1038","volume":"11","author":[{"given":"Hurramhon","family":"Shokirova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takenori","family":"Inomata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Fujio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Yanagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaemyoung","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Nagino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Hirosawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizu","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutsugu","family":"Akasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"88118_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","volume":"57","author":"JH Chang","year":"2012","unstructured":"Chang, J. H. et al. Corneal neovascularization: an anti-VEGF therapy review. Surv. Ophthalmol. 57, 415\u2013429. https:\/\/doi.org\/10.1016\/j.survophthal.2012.01.007 (2012).","journal-title":"Surv. Ophthalmol."},{"key":"88118_CR2","doi-asserted-by":"publisher","unstructured":"Sharif, Z. & Sharif, W. Corneal neovascularization: updates on pathophysiology, investigations & management. Roman. J. Ophthalmol. 63, 15\u201322. https:\/\/doi.org\/10.22336\/rjo.2019.4 (2019)","DOI":"10.22336\/rjo.2019.4"},{"key":"88118_CR3","doi-asserted-by":"publisher","unstructured":"Foster, A. & Resnikoff, S. The impact of Vision 2020 on global blindness. k 0 Eye (Lond) 19, 1133\u20131135, https:\/\/doi.org\/10.1038\/sj.eye.6701973 (2005).","DOI":"10.1038\/sj.eye.6701973"},{"key":"88118_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/s0039-6257(98)00035-6","volume":"43","author":"P Lee","year":"1998","unstructured":"Lee, P., Wang, C. C. & Adamis, A. P. Ocular neovascularization: an epidemiologic review. Surv. Ophthalmol. 43, 245\u2013269. https:\/\/doi.org\/10.1016\/s0039-6257(98)00035-6 (1998).","journal-title":"Surv. Ophthalmol."},{"key":"88118_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archopht.126.1.71","volume":"126","author":"BO Bachmann","year":"2008","unstructured":"Bachmann, B. O. et al. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. Arch. Ophthalmol. 126, 71\u201377. https:\/\/doi.org\/10.1001\/archopht.126.1.71 (2008).","journal-title":"Arch. Ophthalmol."},{"key":"88118_CR6","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1167\/iovs.03-1380","volume":"45","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen, C. et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest. Ophthalmol. Vis. Sci. 45, 2666\u20132673. https:\/\/doi.org\/10.1167\/iovs.03-1380 (2004).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"88118_CR7","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1177\/1947601911423031","volume":"2","author":"M Shibuya","year":"2011","unstructured":"Shibuya, M. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer 2, 1097\u20131105. https:\/\/doi.org\/10.1177\/1947601911423031 (2011).","journal-title":"Genes Cancer"},{"key":"88118_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3980\/j.issn.2222-3959.2015.01.32","volume":"8","author":"NS Abdelfattah","year":"2015","unstructured":"Abdelfattah, N. S. et al. Clinical correlates of common corneal neovascular diseases: a literature review. Int. J. Ophthalmol. 8, 182\u2013193. https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2015.01.32 (2015).","journal-title":"Int. J. Ophthalmol."},{"key":"88118_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41583-018-0028-x","volume":"19","author":"E Darcq","year":"2018","unstructured":"Darcq, E. & Kieffer, B. L. Opioid receptors: Drivers to addiction?. Nat. Rev. Neurosci. 19, 499\u2013514. https:\/\/doi.org\/10.1038\/s41583-018-0028-x (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"88118_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s0301-0082(02)00008-4","volume":"66","author":"BL Kieffer","year":"2002","unstructured":"Kieffer, B. L. & Gav\u00e9riaux-Ruff, C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66, 285\u2013306. https:\/\/doi.org\/10.1016\/s0301-0082(02)00008-4 (2002).","journal-title":"Prog. Neurobiol."},{"key":"88118_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/bja\/aer115","volume":"107","author":"N Dietis","year":"2011","unstructured":"Dietis, N., Rowbotham, D. J. & Lambert, D. G. Opioid receptor subtypes: Fact or artifact?. Br. J. Anaesth. 107, 8\u201318. https:\/\/doi.org\/10.1093\/bja\/aer115 (2011).","journal-title":"Br. J. Anaesth."},{"key":"88118_CR12","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/0024-3205(82)90341-1","volume":"31","author":"MF Piercey","year":"1982","unstructured":"Piercey, M. F., Lahti, R. A., Schroeder, L. A., Einspahr, F. J. & Barsuhn, C. U-50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouse. Life Sci. 31, 1197\u20131200. https:\/\/doi.org\/10.1016\/0024-3205(82)90341-1 (1982).","journal-title":"Life Sci."},{"key":"88118_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1248\/cpb.46.366","volume":"46","author":"H Nagase","year":"1998","unstructured":"Nagase, H. et al. Discovery of a structurally novel opioid kappa-agonist derived from 4,5-epoxymorphinan. Chem Pharm Bull. (Tokyo) 46, 366\u2013369. https:\/\/doi.org\/10.1248\/cpb.46.366 (1998).","journal-title":"Chem Pharm Bull. (Tokyo)"},{"key":"88118_CR14","doi-asserted-by":"publisher","first-page":"9188","DOI":"10.1016\/j.bmc.2008.09.011","volume":"16","author":"K Kawai","year":"2008","unstructured":"Kawai, K. et al. Design, synthesis, and structure-activity relationship of novel opioid kappa-agonists. Bioorg. Med. Chem. 16, 9188\u20139201. https:\/\/doi.org\/10.1016\/j.bmc.2008.09.011 (2008).","journal-title":"Bioorg. Med. Chem."},{"key":"88118_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/s0014-2999(01)01588-6","volume":"435","author":"Y Togashi","year":"2002","unstructured":"Togashi, Y. et al. Antipruritic activity of the kappa-opioid receptor agonist, TRK-820. Eur. J. Pharmacol. 435, 259\u2013264. https:\/\/doi.org\/10.1016\/s0014-2999(01)01588-6 (2002).","journal-title":"Eur. J. Pharmacol."},{"key":"88118_CR16","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1038\/srep03213","volume":"3","author":"K Yamamizu","year":"2013","unstructured":"Yamamizu, K. et al. \u043a Opioids inhibit tumor angiogenesis by suppressing VEGF signaling. Sci. Rep. 3, 3213. https:\/\/doi.org\/10.1038\/srep03213 (2013).","journal-title":"Sci. Rep."},{"key":"88118_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/ccid.S55942","volume":"8","author":"S Inui","year":"2015","unstructured":"Inui, S. Nalfurafine hydrochloride to treat pruritus: a review. Clin. Cosmet. Investig. Dermatol. 8, 249\u2013255. https:\/\/doi.org\/10.2147\/ccid.S55942 (2015).","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"88118_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ccr.2006.10.018","volume":"11","author":"Q Pan","year":"2007","unstructured":"Pan, Q. et al. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell 11, 53\u201367. https:\/\/doi.org\/10.1016\/j.ccr.2006.10.018 (2007).","journal-title":"Cancer Cell"},{"key":"88118_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/ICO.0000000000001400","volume":"37","author":"T Inomata","year":"2018","unstructured":"Inomata, T. et al. Corneal tissue from dry eye donors leads to enhanced graft rejection. Cornea 37, 95\u2013101. https:\/\/doi.org\/10.1097\/ICO.0000000000001400 (2018).","journal-title":"Cornea"},{"key":"88118_CR20","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1210\/en.2005-0790","volume":"147","author":"YJ Lin","year":"2006","unstructured":"Lin, Y. J., Lai, M. D., Lei, H. Y. & Wing, L. Y. Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model. Endocrinology 147, 1278\u20131286. https:\/\/doi.org\/10.1210\/en.2005-0790 (2006).","journal-title":"Endocrinology"},{"key":"88118_CR21","doi-asserted-by":"publisher","first-page":"19817","DOI":"10.1038\/s41598-020-76882-w","volume":"10","author":"T Inomata","year":"2020","unstructured":"Inomata, T. et al. Novel immunotherapeutic effects of topically administered ripasudil (K-115) on corneal allograft survival. Sci. Rep. 10, 19817. https:\/\/doi.org\/10.1038\/s41598-020-76882-w (2020).","journal-title":"Sci. Rep."},{"key":"88118_CR22","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3389\/fimmu.2014.00508","volume":"5","author":"C Tecchio","year":"2014","unstructured":"Tecchio, C., Micheletti, A. & Cassatella, M. A. Neutrophil-derived cytokines: facts beyond expression. Front. Immunol. 5, 508. https:\/\/doi.org\/10.3389\/fimmu.2014.00508 (2014).","journal-title":"Front. Immunol."},{"key":"88118_CR23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3389\/fimmu.2014.00491","volume":"5","author":"G Arango Duque","year":"2014","unstructured":"Arango Duque, G. & Descoteaux, A. Macrophage cytokines: involvement in immunity and infectious diseases. Front. Immunol. 5, 491. https:\/\/doi.org\/10.3389\/fimmu.2014.00491 (2014).","journal-title":"Front. Immunol."},{"key":"88118_CR24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/TP.0000000000001044","volume":"100","author":"M Tahvildari","year":"2016","unstructured":"Tahvildari, M. et al. In vivo expansion of regulatory t cells by low-dose interleukin-2 treatment increases allograft survival in corneal transplantation. Transplantation 100, 525\u2013532. https:\/\/doi.org\/10.1097\/TP.0000000000001044 (2016).","journal-title":"Transplantation"},{"key":"88118_CR25","doi-asserted-by":"crossref","unstructured":"Afsaneh Amouzegar, S. K. C., Reza Dana. Alloimmunity and tolerance in corneal transplantation. J. Immunol. 196, 3983\u20133991 (2016).","DOI":"10.4049\/jimmunol.1600251"},{"key":"88118_CR26","doi-asserted-by":"publisher","unstructured":"Tahvildari, M., Inomata, T., Amouzegar, A. & Dana, R. Regulatory T Cell Modulation of Cytokine and Cellular Networks in Corneal Graft Rejection. Curr Ophthalmol Rep 6, 2Am 6\u2013274, https:\/\/doi.org\/10.1007\/s40135-018-0191-2 (2018).","DOI":"10.1007\/s40135-018-0191-2"},{"key":"88118_CR27","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1167\/iovs.11-8742","volume":"53","author":"T Inomata","year":"2012","unstructured":"Inomata, T. et al. Perlecan-deficient mutation impairs corneal epithelial structure. Invest. Ophthalmol. Vis. Sci. 53, 1277\u20131284. https:\/\/doi.org\/10.1167\/iovs.11-8742 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"88118_CR28","doi-asserted-by":"publisher","first-page":"e90576","DOI":"10.1371\/journal.pone.0090576","volume":"9","author":"VO Zambelli","year":"2014","unstructured":"Zambelli, V. O. et al. Peripheral sensitization increases opioid receptor expression and activation by crotalphine in rats. PLoS ONE 9, e90576. https:\/\/doi.org\/10.1371\/journal.pone.0090576 (2014).","journal-title":"PLoS ONE"},{"key":"88118_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.exer.2010.03.019","volume":"91","author":"SE Yanni","year":"2010","unstructured":"Yanni, S. E., McCollum, G. W. & Penn, J. S. Genetic deletion of COX-2 diminishes VEGF production in mouse retinal M\u00fcller cells. Exp. Eye Res. 91, 34\u201341. https:\/\/doi.org\/10.1016\/j.exer.2010.03.019 (2010).","journal-title":"Exp. Eye Res."},{"key":"88118_CR30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00213-010-1806-y","volume":"210","author":"MR Bruchas","year":"2010","unstructured":"Bruchas, M. R. & Chavkin, C. Kinase cascades and ligand-directed signaling at the kappa opioid receptor. Psychopharmacology 210, 137\u2013147. https:\/\/doi.org\/10.1007\/s00213-010-1806-y (2010).","journal-title":"Psychopharmacology"},{"key":"88118_CR31","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/s12885-017-3541-9","volume":"17","author":"D Chen","year":"2017","unstructured":"Chen, D. et al. Down-regulation of the tumour suppressor \u03ba-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. BMC Cancer 17, 553. https:\/\/doi.org\/10.1186\/s12885-017-3541-9 (2017).","journal-title":"BMC Cancer"},{"key":"88118_CR32","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1182\/blood-2010-09-306001","volume":"118","author":"K Yamamizu","year":"2011","unstructured":"Yamamizu, K. et al. The kappa opioid system regulates endothelial cell differentiation and pathfinding in vascular development. Blood 118, 775\u2013785. https:\/\/doi.org\/10.1182\/blood-2010-09-306001 (2011).","journal-title":"Blood"},{"key":"88118_CR33","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/bph.12573","volume":"172","author":"K Yamamizu","year":"2015","unstructured":"Yamamizu, K., Hamada, Y. & Narita, M. kappa Opioid receptor ligands regulate angiogenesis in development and in tumours. Br. J. Pharmacol. 172, 268\u2013276. https:\/\/doi.org\/10.1111\/bph.12573 (2015).","journal-title":"Br. J. Pharmacol."},{"key":"88118_CR34","doi-asserted-by":"publisher","first-page":"39924","DOI":"10.1038\/srep39924","volume":"6","author":"T Inomata","year":"2016","unstructured":"Inomata, T., Hua, J., Di Zazzo, A. & Dana, R. Impaired function of peripherally induced regulatory T cells in hosts at high risk of graft rejection. Sci. Rep. 6, 39924. https:\/\/doi.org\/10.1038\/srep39924 (2016).","journal-title":"Sci. Rep."},{"key":"88118_CR35","doi-asserted-by":"publisher","unstructured":"Di Zazzo, A. et al. Variable responses to corneal grafts: insights from immunology and systems biology. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm9020586 (2020).","DOI":"10.3390\/jcm9020586"},{"key":"88118_CR36","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1600-0420.2004.00312.x","volume":"82","author":"L Gan","year":"2004","unstructured":"Gan, L., Fagerholm, P. & Palmblad, J. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing. Acta Ophthalmol. Scand. 82, 557\u2013563. https:\/\/doi.org\/10.1111\/j.1600-0420.2004.00312.x (2004).","journal-title":"Acta Ophthalmol. Scand."},{"key":"88118_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2018.07.005","author":"X Tan","year":"2018","unstructured":"Tan, X. et al. The immunoregulatory role of corneal epithelium-derived thrombospondin-1 in dry eye disease. Ocul. Surf. https:\/\/doi.org\/10.1016\/j.jtos.2018.07.005 (2018).","journal-title":"Ocul. Surf."},{"key":"88118_CR38","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/TP.0000000000001390","volume":"101","author":"A Di Zazzo","year":"2017","unstructured":"Di Zazzo, A. et al. Proangiogenic function of T cells in corneal transplantation. Transplantation 101, 778\u2013785. https:\/\/doi.org\/10.1097\/TP.0000000000001390 (2017).","journal-title":"Transplantation"},{"key":"88118_CR39","doi-asserted-by":"publisher","first-page":"7059","DOI":"10.1038\/s41598-018-25384-x","volume":"8","author":"J Hua","year":"2018","unstructured":"Hua, J. et al. Pathological conversion of regulatory T cells is associated with loss of allotolerance. Sci. Rep. 8, 7059. https:\/\/doi.org\/10.1038\/s41598-018-25384-x (2018).","journal-title":"Sci. Rep."},{"key":"88118_CR40","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1182\/blood-2010-09-306001","volume":"118","author":"K Yamamizu","year":"2011","unstructured":"Yamamizu, K. et al. The \u03ba opioid system regulates endothelial cell differentiation and pathfinding in vascular development. Blood 118, 775\u2013785. https:\/\/doi.org\/10.1182\/blood-2010-09-306001 (2011).","journal-title":"Blood"},{"key":"88118_CR41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/ICO.0000000000001127","volume":"36","author":"T Inomata","year":"2017","unstructured":"Inomata, T. et al. Kinetics of angiogenic responses in corneal transplantation. Cornea 36, 491\u2013496. https:\/\/doi.org\/10.1097\/ICO.0000000000001127 (2017).","journal-title":"Cornea"},{"key":"88118_CR42","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/bph.12573","volume":"172","author":"K Yamamizu","year":"2015","unstructured":"Yamamizu, K., Hamada, Y. & Narita, M. \u03ba Opioid receptor ligands regulate angiogenesis in development and in tumours. Br. J. Pharmacol. 172, 268\u2013276. https:\/\/doi.org\/10.1111\/bph.12573 (2015).","journal-title":"Br. J. Pharmacol."},{"key":"88118_CR43","doi-asserted-by":"publisher","first-page":"625","DOI":"10.18240\/ijo.2016.04.25","volume":"9","author":"NS Abdelfattah","year":"2016","unstructured":"Abdelfattah, N. S., Amgad, M. & Zayed, A. A. Host immune cellular reactions in corneal neovascularization. Int. J. Ophthalmol. 9, 625\u2013633. https:\/\/doi.org\/10.18240\/ijo.2016.04.25 (2016).","journal-title":"Int. J. Ophthalmol."},{"key":"88118_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/08820538.2011.588652","volume":"26","author":"JL Clements","year":"2011","unstructured":"Clements, J. L. & Dana, R. Inflammatory corneal neovascularization: etiopathogenesis. Semin. Ophthalmol. 26, 235\u2013245. https:\/\/doi.org\/10.3109\/08820538.2011.588652 (2011).","journal-title":"Semin. Ophthalmol."},{"key":"88118_CR45","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1167\/iovs.15-17551","volume":"57","author":"J Hua","year":"2016","unstructured":"Hua, J. et al. Graft site microenvironment determines dendritic cell trafficking through the CCR7-CCL19\/21 Axis. Invest. Ophthalmol. Vis. Sci. 57, 1457\u20131467. https:\/\/doi.org\/10.1167\/iovs.15-17551 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"88118_CR46","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.4049\/jimmunol.1600251","volume":"196","author":"A Amouzegar","year":"2016","unstructured":"Amouzegar, A., Chauhan, S. K. & Dana, R. Alloimmunity and tolerance in corneal transplantation. J. Immunol. 196, 3983\u20133991. https:\/\/doi.org\/10.4049\/jimmunol.1600251 (2016).","journal-title":"J. Immunol."},{"key":"88118_CR47","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ejphar.2013.01.076","volume":"716","author":"C Stein","year":"2013","unstructured":"Stein, C. Opioids, sensory systems and chronic pain. Eur. J. Pharmacol. 716, 179\u2013187. https:\/\/doi.org\/10.1016\/j.ejphar.2013.01.076 (2013).","journal-title":"Eur. J. Pharmacol."},{"key":"88118_CR48","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s0301-0082(02)00008-4","volume":"66","author":"BL Kieffer","year":"2002","unstructured":"Kieffer, B. L. & Gaveriaux-Ruff, C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66, 285\u2013306. https:\/\/doi.org\/10.1016\/s0301-0082(02)00008-4 (2002).","journal-title":"Prog. Neurobiol."},{"key":"88118_CR49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.brainres.2003.09.057","volume":"995","author":"T Suzuki","year":"2004","unstructured":"Suzuki, T. et al. Effect of repeated administration of TRK-820, a kappa-opioid receptor agonist, on tolerance to its antinociceptive and sedative actions. Brain Res. 995, 167\u2013175. https:\/\/doi.org\/10.1016\/j.brainres.2003.09.057 (2004).","journal-title":"Brain Res."},{"key":"88118_CR50","doi-asserted-by":"publisher","unstructured":"Beck, T. C., Hapstack, M. A., Beck, K. R. & Dix, T. A. Therapeutic potential of kappa opioid agonists. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph12020095 (2019).","DOI":"10.3390\/ph12020095"},{"key":"88118_CR51","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.4049\/jimmunol.1003239","volume":"186","author":"A Suryawanshi","year":"2011","unstructured":"Suryawanshi, A. et al. Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor. J. Immunol. 186, 3653\u20133665. https:\/\/doi.org\/10.4049\/jimmunol.1003239 (2011).","journal-title":"J. Immunol."},{"key":"88118_CR52","doi-asserted-by":"publisher","unstructured":"Inomata T, Mashaghi A, Di Zazzo A & R., D. Ocular surgical models for immune and angiogenic responses. J Biol Methods 2(3):e27. https:\/\/doi.org\/10.14440\/jbm.2015.78 (2015).","DOI":"10.14440\/jbm.2015.78"},{"key":"88118_CR53","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.14440\/jbm.2018.237","volume":"5","author":"M Ogawa","year":"2018","unstructured":"Ogawa, M., Inomata, T., Shiang, T., Tsubota, K. & Murakami, A. Method for selective quantification of immune and inflammatory cells in the cornea using flow cytometry. J Biol Methods 5, e102. https:\/\/doi.org\/10.14440\/jbm.2018.237 (2018).","journal-title":"J Biol Methods"},{"key":"88118_CR54","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1167\/iovs.14-14356","volume":"55","author":"J Hua","year":"2014","unstructured":"Hua, J. et al. The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation. Invest. Ophthalmol. Vis. Sci. 55, 5944\u20135951. https:\/\/doi.org\/10.1167\/iovs.14-14356 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"88118_CR55","doi-asserted-by":"publisher","first-page":"2","DOI":"10.14789\/jmj.63.2","volume":"63","author":"T Inomata","year":"2017","unstructured":"Inomata, T. A new immunotherapy using regulatory T-cells for high-risk corneal transplantation. Juntendo Med. J. 63, 2\u20137. https:\/\/doi.org\/10.14789\/jmj.63.2 (2017).","journal-title":"Juntendo Med. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88118-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88118-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88118-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:00:39Z","timestamp":1670032839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88118-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88118"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88118-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-122445\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,21]]},"assertion":[{"value":"5 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.I., T.S., H.N., and A.M. have a patent application pending for CNV Suppressant Properties of nalfurafine. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8647"}}